Assessing adverse drug reaction reports for antidiabetic medications approved by the food and drug administration between 2012 and 2017: a pharmacovigilance study.

Britney A StottlemyerMichael C McDermottMackenzie R MinogueMatthew P GrayRichard D BoyceSandra L Kane-Gill

Published in: Therapeutic advances in drug safety (2023)

Pharmacovigilance studies utilizing a large publicly available dataset allow an essential opportunity to evaluate the safety profile of antidiabetic drugs utilized in clinical practice. Additional research is needed to evaluate these reported safety concerns for recently approved antidiabetic medications to determine causality.

Keyphrases

adverse drug
drug administration
clinical practice
electronic health record
drug induced
emergency department
climate change